S. Denmeade

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death

Rong Na, S. Lilly Zheng, Misop Han et al. · European Urology · 2016 · 335 citations · Full text

Urology, Oncology, Early Age +8

A 5-fluorodeoxyuridine prodrug as targeted therapy for prostate cancer

Annastasiah Mhaka, S. Denmeade, Wei Yao et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 39 citations

Medicine, Pharmacology, Pharmacotherapy +4

A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)

Hamza Hasan, Matthew P. Deek, Ryan Phillips et al. · BMC Cancer · 2020 · 32 citations · Full text

Phase II multicenter study of abiraterone acetate (AA) plus prednisone therapy in docetaxel-treated castration-resistant prostate cancer (CRPC) patients (pts): Impact of prior ketoconazole (keto)

Daniel C. Danila, Johann S. de Bono, Charles J. Ryan et al. · Journal of Clinical Oncology · 2009 · 18 citations

Aa Antitumor Activity, Urology, Oncology +15

MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression

Jiayu Chen, Qizhi Zheng, Jessica Hicks et al. · JCI Insight · 2023 · 14 citations · Full text

Cancer Biology, Tumor Biology, Tumor Heterogeneity +16